GBA1 and Parkinson disease: Such an analysis in PD is important, as it has been demonstrated that PD patients with LRRK2 mutations display distinct pathology and clinical manifestations in comparison to those with GBA1 mutations or non-carrier PD patients (NC-PDs) [11].